Edition:
India

Morepen Laboratories Ltd (MORL.NS)

MORL.NS on National Stock Exchange of India

21.65INR
21 Feb 2017
Change (% chg)

-- (--)
Prev Close
Rs21.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
856,307
52-wk High
Rs30.80
52-wk Low
Rs18.00

MORL.NS

Chart for MORL.NS

About

Morepen Laboratories Limited is a pharmaceutical company. The Company's divisions include Active Pharmaceutical Ingredients (API), Home Diagnostics and Finished Formulations. The API division offers products, such as Loratadine Process-1, Desloratadine, Atorvastatin Calcium Amorphous, Atorvastatin Calcium Crystalline Form VI and... (more)

Overall

Beta: 0.81
Market Cap(Mil.): Rs9,738.74
Shares Outstanding(Mil.): 449.83
Dividend: --
Yield (%): --

Financials

  MORL.NS Industry Sector
P/E (TTM): -- 28.45 29.35
EPS (TTM): -0.79 -- --
ROI: -- 13.47 12.97
ROE: -- 14.36 14.11

BRIEF-Morepen Laboratories Dec-qtr profit falls

* Dec quarter net profit 42.7 million rupees versus profit 72.8 million rupees year ago

08 Feb 2017

BRIEF-Morepen Laboratories Sept qtr profit rises

* Sept quarter net profit 70.3 million rupees versus profit 32.2 million rupees year ago

09 Nov 2016

BRIEF-Morepen Labs deny talks to sell OTC business to Piramals

* Clarifies on news item "Morepen in talks to sell OTC business to Piramals".

23 Sep 2016

More From Around the Web

Earnings vs. Estimates